Skip to main content

ADVERTISEMENT

Nicole J. Brandt, PharmD, MBA, BCGP, FASCP

Commentary
12/14/2023
Stakeholder interest is high in progressing beyond the current targeting criteria and requirement for an annual comprehensive medication review, but a significant regulatory hurdle exists. Beyond this hurdle, beneficiary involvement and...
Stakeholder interest is high in progressing beyond the current targeting criteria and requirement for an annual comprehensive medication review, but a significant regulatory hurdle exists. Beyond this hurdle, beneficiary involvement and...
Stakeholder interest is high in...
12/14/2023
Pharmacy Learning Network